Antibiotic Resistance

Significant variations in global rates of infection, culture-positivity and drug resistance serve as a “call to action” to streamline antibiotic use and improve outcomes among inpatients with cirrhosis, according to researchers.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Penny A. Asbell, MD, FACS, MBA, of the University of Memphis, discusses results from the ARMOR surveillance study.

De-escalation of beta-lactam antibiotics was associated with a decreased risk of new resistance development compared with no change in beta-lactam antibiotic use, researchers found.

Being a medical student in the early 2000s, I never would have imagined going into infectious diseases. It never really crossed my mind until I started residency and actually “did the work.”

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Penny A. Asbell, MD, FACS, MBA, overviews the ARMOR study and antibiotic resistance in eye infections.

Study findings from hospitals in Copenhagen add to growing data that shorter antibiotic treatment duration is effective for patients with gram-negative bacteremia.

The FDA approved updated COVID-19 vaccines last week that target omicron XBB subvariants of SARS-CoV-2, which have become the predominant SARS-CoV-2 viruses worldwide.

After assessing Klebsiella pneumoniae bloodstream infections, researchers are calling for more rapid identification methods to find patients with resistant infections because choosing the wrong first antibiotics increases mortality risk.

PHILADELPHIA — At this year’s World Anti-Microbial Resistance Congress, Ricardo Chaves, MD, PhD, the executive medical director of clinical development at Debiopharm, moderated a panel on novel antibiotics.

Antimicrobial peptides are touted as potential new antibiotics to help treat ocular surface infections. Yet, we have been using these since at least the 1970s.